(Q37740949)

22 August 2017

1 reference

title

Pathology of hereditary breast cancer (English)

1 reference

22 August 2017

0 references

1 reference

2

Sunil R Lakhani

1 reference

22 August 2017

Leonard Da Silva

1

1 reference

22 August 2017

publication date

1 May 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

23 Suppl 2

1 reference

22 August 2017

page(s)

S46-51

1 reference

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

ATM and ataxia telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

The CHEK2 gene and inherited breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

The emerging landscape of breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Linkage of early-onset familial breast cancer to chromosome 17q21

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

The pathology of inherited breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Cancer susceptibility and the functions of BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Low expression of bcl-2 in Brca1-associated breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

BRCA1 dysfunction in sporadic basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Optimal selection of individuals for BRCA mutation testing: a comparison of available methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

No evidence for germline PTEN mutations in families with breast and brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Genome-wide association study identifies novel breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Targeting the DNA repair defect of BRCA tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Immunohistochemical Expression of DNA Repair Proteins in Familial Breast Cancer DifferentiateBRCA2-Associated Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Clinical Classification ofBRCA1andBRCA2DNA Sequence Variants: The Value of Cytokeratin Profiles and Evolutionary Analysis—A Report From the kConFab Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

Age at onset as an indicator of familial risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

7 January 2021

The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

7 January 2021

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

7 January 2021

Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

7 January 2021

Histopathological features of breast cancer in carriers of ATM gene variants

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.37

7 January 2021

10.1038/MODPATHOL.2010.37

Identifiers

DOI

1 reference

22 August 2017

1 reference